Loading

Loading...

Search Results For ‘ FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics

news

U.S. Food and Drug Administration issued a final guidance for industry titled Postapproval Pregnancy Safety Studies on May 8, 2026. The guidance provides recommendations on…